Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

The Use of Incretin-Based Drugs and SGLT-2 Inhibitors for the Prevention of Parkinson's Disease Among Patients with Type 2 Diabetes

FY 2024-25

Summary
Patients with type 2 diabetes (high blood sugar) have an increased risk of developing Parkinson's disease. However, it is uncertain whether lowering blood sugar can help prevent Parkinson's disease in patients with diabetes. Some newer blood sugar lowering medications are of particular interest because they not only decrease blood sugar levels but may also have a direct effect on the brain and provide additional protection against Parkinson's disease. Thus, I will evaluate whether individuals who are treated with these newer medications have a lower risk of Parkinson's disease compared with individuals who are treated with an older, more common antidiabetic drug used at the same stage of diabetes but without any effect on the brain. To perform this study, I will use a database with medical information from millions of patients. I will then select patients with diabetes treated with the older medication and compare them to patients treated with the newer medications to determine whether those treated with the newer medications are less diagnosed with Parkinson's disease. The proposed research project will provide information on the potential benefit of the newer blood sugar lowering medications in preventing Parkinson's disease. If we show that these drugs are beneficial, this study will provide important information to inform prescription choices in the management of individuals with type 2 diabetes and could improve the future health outcomes of these patients. Our results could also stimulate further research into the potential use of these blood sugar lowering drugs to prevent Parkinson's disease in patients without diabetes.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
517188
Name
Khuong Ninh
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
The Use of Incretin-Based Drugs and SGLT-2 Inhibitors for the Prevention of Parkinson's Disease Among Patients with Type 2 Diabetes
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cohort Study; Electronic Medical Records; Incretin-Based Drugs; Parkinson'S Disease; Pharmacoepidemiology; Sglt-2 Inhibitors
Abstract
Patients with type 2 diabetes (high blood sugar) have an increased risk of developing Parkinson's disease. However, it is uncertain whether lowering blood sugar can help prevent Parkinson's disease in patients with diabetes. Some newer blood sugar lowering medications are of particular interest because they not only decrease blood sugar levels but may also have a direct effect on the brain and provide additional protection against Parkinson's disease. Thus, I will evaluate whether individuals who are treated with these newer medications have a lower risk of Parkinson's disease compared with individuals who are treated with an older, more common antidiabetic drug used at the same stage of diabetes but without any effect on the brain. To perform this study, I will use a database with medical information from millions of patients. I will then select patients with diabetes treated with the older medication and compare them to patients treated with the newer medications to determine whether those treated with the newer medications are less diagnosed with Parkinson's disease. The proposed research project will provide information on the potential benefit of the newer blood sugar lowering medications in preventing Parkinson's disease. If we show that these drugs are beneficial, this study will provide important information to inform prescription choices in the management of individuals with type 2 diabetes and could improve the future health outcomes of these patients. Our results could also stimulate further research into the potential use of these blood sugar lowering drugs to prevent Parkinson's disease in patients without diabetes.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Khuong, Ninh
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
McGill University - $150,000 Grant (2024-25) | Canada Spends